Latest News

These two Canadian dividend powerhouses offer attractive yields, encouraging earnings trends, and growth opportunities that could strengthen your portfolio over time.

Aritzia (TSX:ATZ) is a generational growth stock that could double sales in five years. Its stock might be in for huge upside.

Is Brookfield stock a buy, sell or hold for 2027? Explore its latest earnings, insurance expansion and potential for long-term growth.

Boyd Group stock is down 59%, yet Q2 sales topped US$1 billion and margins hit 13.4%. See why this TSX stock is an undervalued buy in November 2026.

CARFAX is an increasingly valuable information source for the auto industry.

You can build a rewarding passive-income portfolio with just $35,000 by investing in these two attractive TSX dividend stocks, offering regular cash payouts and long-term growth potential.

Bank of Nova Scotia (TSX:BNS) could still keep winning as shares look to breakout, even as AI weakness tests the stock market.

Replacing a $500 monthly bill starts with a realistic capital target and an income plan that can grow.

INVE Technologies (NASDAQ:INVE) reported third-quarter revenue of $3.1 million and said it currently has no commercial operating revenue following the September sale of its Internet of Things business to Trackonomy. The company, formerly known as Identiv, is shifting its focus toward acquiring ente

Codexis (NASDAQ:CDXS) reported higher third-quarter revenue and a narrower loss as its pharmaceutical biocatalysis business grew, while executives outlined progress toward commercial adoption of the company’s ECO Synthesis platform for manufacturing oligonucleotide medicines. Revenue rose to $19.3

Cisco Systems (NASDAQ:CSCO) raised its fiscal 2027 revenue and earnings outlook after reporting record first-quarter sales, as demand for networking equipment and artificial intelligence infrastructure drove its strongest revenue and earnings growth rates in more than 15 years. Revenue rose 24% yea

Fidelity National Information Services (NYSE:FIS) Chief Executive Stephanie Ferris said the company is working to rebuild investor credibility after client implementation delays and higher spending on cybersecurity and resiliency contributed to a reset of its 2027 outlook. Ferris said several large

Journey Medical reported third-quarter revenue of $19 million and a narrower net loss as sales of its rosacea treatment EMROSI grew and the company expanded insurance coverage for the drug. The company said EMROSI generated $9 million in net sales during the quarter, supported by higher prescriptio

Cerebras Systems (NASDAQ:CBRS) raised its 2026 financial outlook after reporting record third-quarter core revenue and announcing a cloud agreement with Microsoft, while executives said data center delays have put portions of its OpenAI contract behind schedule. Chief Executive Officer Andrew Feldm

Management says regulatory noise isn't dampening data center demand for its gear.

Explore the Big Six, their latest earnings and dividend yields, with income and defensive picks.

Canada’s banking sector is a bedrock of stability but a Big Bank stock stands out if you’re investing before 2026 ends.

A proprietary transmission design carrying six times more power could reshape how utilities monetize grid upgrades for decades.

The better pick depends on whether you want growth or steady income.

Record quarterly output and Boumadine economics drive the story.

Record free cash flow arrived alongside an accelerated lunar satellite timeline.

Digital growth surged, but wage pressure weighed on margins this quarter.

Tuck-in acquisitions and specialty testing momentum give Labcorp tools to offset a looming $125 million Medicare reimbursement hit.

Zelsuvmi growth accelerates as a gene therapy deal takes shape.

New AI product debuted strongly while a U.S. redomicile move advances.